drugset / Trial / NCT00108433

Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections

NCT00108433

Phase 3 Terminated 61 enrolled Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will treat hemodialysis patients who have a central catheter that is thought to be infected with a specific bacteria (Gram positive bacteria).

Timeline

Start
2005-09
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Cefazolin Small molecule Intravenous
Subject Linezolid Other / unclassified Intravenous
Subject Vancomycin Other / unclassified Intravenous